Back to Pediatrics
Pediatricsv2008Evidence-Based

Withdrawal Assessment Tool (WAT-1) for Pediatric Withdrawal

Validated assessment tool for evaluating opioid and benzodiazepine withdrawal severity in pediatric patients. The WAT-1 systematically assesses 12 clinical parameters across multiple domains including neurologic irritability, motor symptoms, respiratory distress, and gastrointestinal symptoms to guide withdrawal management in children.

Clinical Input Parameters

weeks
Range: 25 — 200 weeks
points
points
points
points
points
points
points
points
points
points
points
Clinical Assessment
Awaiting Parameters
wat 1 score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Withdrawal Assessment Tool (WAT-1) for Pediatric Withdrawal is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pediatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of scores for 12 withdrawal assessment parameters (0-3 points each): state/sleep-wake cycle + tremor + increased muscle tone + excoriation + myoclonus/seizures + tachypnea + sweating + fever + frequent yawning/sneezing + nasal stuffiness + poor feeding/vomiting. Post-menstrual age affects interpretation thresholds.

Clinical Pearls & Practice Notes

  • Validated for pediatric patients (term infants to 18 years)
  • Assesses withdrawal from opioids and benzodiazepines
  • Should be assessed every 4-12 hours during withdrawal period
  • Scores ≥3 typically warrant pharmacological intervention
  • Post-menstrual age affects expected baseline behaviors
  • Younger patients may have different manifestations
  • Consider environmental factors affecting assessment
  • Tool helps standardize withdrawal assessment across providers
  • Useful for guiding weaning protocols and medication decisions
  • Should be used in conjunction with clinical judgment
  • Requires training for reliable administration
  • Not validated for alcohol or other substance withdrawal
  • Environmental modifications may help reduce scores
  • Family presence and comfort measures are important adjuncts
  • Consider pain vs withdrawal as differential diagnosis
  • Age-appropriate comfort measures should be implemented

Evidence & Literature Citations

  1. Franck LS, Harris SK, Soetenga DJ, et al. The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients. Pediatr Crit Care Med. 2008;9(6):573-580. doi: 10.1097/PCC.0b013e31818c8328
  2. Anand KJ, Willson DF, Berger J, et al. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics. 2010;125(5):e1208-e1225. doi: 10.1542/peds.2009-0489
  3. Ista E, van Dijk M, Gamel C, et al. Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. Assessment remains troublesome. Intensive Care Med. 2007;33(8):1396-1406. doi: 10.1007/s00134-007-0696-x
  4. Best KM, Asaro LA, Franck LS. Patterns of sedation weaning in critically ill children recovering from acute respiratory failure. Pediatr Crit Care Med. 2015;16(3):e43-e49. doi: 10.1097/PCC.0000000000000324

Score Interpretation Ranges

None to Mild0 – 2 pts

No withdrawal or mild withdrawal symptoms

Mild to Moderate3 – 8 pts

Mild to moderate withdrawal symptoms

Moderate to Severe9 – 36 pts

Moderate to severe withdrawal symptoms

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.